Clinical Trial

Clinical Trial to Evaluate the Efficacy and Safety of DW4902

Name: Clinical Trial to Evaluate the Efficacy and Safety of DW4902 — clinical trial record (NCT07319520)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 2

View on ClinicalTrials.gov →

Summary

A Multi-center, Randomized, Double-blind, Placebo-controlled, Therapeutic Exploratory, Phase II Clinical Trial for the Efficacy Investigation and Safety Evaluation of DW4902 in Patients with Uterine Fibroids.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-12-22.

Trial Details

NCT Number	NCT07319520
Lead Sponsor	Daewon Pharmaceutical Co., Ltd.
Conditions	Myoma of Uterus
Enrollment	71 participants
Start Date	2021-10-06
Primary Completion	2024-11-11 (estimated)
Study Completion	2024-11-11 (estimated)
Updated on ClinicalTrials.gov	2026-01-07